Update on review of Besremi for the treatment of PV in Ireland

The NCPE, the body that assesses and recommends drugs for use by the health services in Ireland, has recently released initial advice following their assessment of ropeginterferon alfa-2b (Besremi) for the treatment of patients with Polycythaemia Vera. As part of that assessment process MPN Voice made a patient group submission highlighting the benefits of Besremi…

Interferon supplies – Update 19 August 2024

Interferon supplies – Update 19 August 2024 For some time we have been aware that there are international shortages of interferon alpha, in particular pegasys (pegylated interferon alpha 2a). We have been liaising via our medical team with the national pharmacy and procurement teams looking at advice and options.  This includes the possibility of using…